However, after adjusting for age, gender, drinking and smoking status, hypertension, control of diabetes and hypertension and use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), this negative association of MS and eGFR remained intact. This evidence concerns the gene ACE and myeloid sarcoma.